Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer
Open Access
- 12 April 2020
- Vol. 12 (4), 956
- https://doi.org/10.3390/cancers12040956
Abstract
Ovarian cancer (OC) is the deadliest gynecologic malignancy with a substantial proportion of hereditary cases and a frequent association with breast cancer (BC). Genetic testing facilitates treatment and preventive strategies reducing OC mortality in mutation carriers. However, the prevalence of germline mutations varies among populations and many rarely mutated OC predisposition genes remain to be identified. We aimed to analyze 219 genes in 1333 Czech OC patients and 2278 population-matched controls using next-generation sequencing. We revealed germline mutations in 18 OC/BC predisposition genes in 32.0% of patients and in 2.5% of controls. Mutations in BRCA1/BRCA2, RAD51C/RAD51D, BARD1, and mismatch repair genes conferred high OC risk (OR > 5). Mutations in BRIP1 and NBN were associated with moderate risk (both OR = 3.5). BRCA1/2 mutations dominated in almost all clinicopathological subgroups including sporadic borderline tumors of ovary (BTO). Analysis of remaining 201 genes revealed somatic mosaics in PPM1D and germline mutations in SHPRH and NAT1 associating with a high/moderate OC risk significantly; however, further studies are warranted to delineate their contribution to OC development in other populations. Our findings demonstrate the high proportion of patients with hereditary OC in Slavic population justifying genetic testing in all patients with OC, including BTO.Keywords
Funding Information
- Ministerstvo Zdravotnictví Ceské Republiky (16-29959A, NV17-32030A, NV18-03-00024, NU20-03-00016, DRO (FNOl, 00098892))
- Univerzita Karlova v Praze (SVV2019/260367, PROGRES Q28/LF1, CZ.02.1.01/0.0/0.0/16_013/0001634)
This publication has 55 references indexed in Scilit:
- Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review)Oncology Letters, 2013
- Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpointThe Journal of cell biology, 2013
- Germline RAD51C mutations confer susceptibility to ovarian cancerNature Genetics, 2012
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingProceedings of the National Academy of Sciences, 2011
- Germline mutations in RAD51D confer susceptibility to ovarian cancerNature Genetics, 2011
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical ImpactJournal of Clinical Oncology, 2008
- BRCA Mutation Frequency and Penetrance: New Data, Old DebateJNCI Journal of the National Cancer Institute, 2006
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Hereditary Colorectal CancerNew England Journal of Medicine, 2003
- The Clinical Features of Ovarian Cancer in Hereditary Nonpolyposis Colorectal CancerGynecologic Oncology, 2001